Feed VVOS
VV

Vivos Therapeutics, Inc.

VVOS · NASDAQ

$0.16 -4.13% (-$0.01)
1M -41.04%
Market Cap $2.22M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.11x
PEG N/A
P/B N/A
Growth
34 /100
Stable
Rev. growth 2.87%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak
Net margin 122.42%
Op. margin 107.92%
FCF margin 81.88%
Quality
15 /100
Poor
ROA 105.97%
Asset turnover 0.87x
ROIC 182.30%
Debt
0 /100
High
Int. coverage -22.30x
Current ratio 0.21x
Net debt/EBITDA N/A
Stability
38 /100
Moderate
Rev. volatility 15.63%
EPS volatility 37.24%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about VVOS
Online

About the company

Vivos Therapeutics, Inc. (VVOS) is a company specializing in the treatment of sleep and breathing disorders, particularly obstructive sleep apnea. The company develops and commercializes therapeutic devices and solutions that assist patients with breathing difficulties during sleep. Vivos Therapeutics aims to improve sleep quality and patient health by focusing on strengthening the upper airway and enhancing ventilation. The company plays a pivotal role in the field of sleep medicine and respiratory disorders. Shares of Vivos Therapeutics, Inc. (VVOS) can be an interesting choice for investors tracking the healthcare sector and innovations in the treatment of sleep disorders.

Sector

Healthcare

Industry

Medical - Devices

CEO

R. Kirk Huntsman

Employees

268

Headquarters

Littleton

Upcoming events

18 NOV

Earnings

Upcoming earnings report

57d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.